Loading clinical trials...
Loading clinical trials...
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients (pRNA-COVID-ICU)
Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Groupe Hospitalier Sud Ile de France, Hôpital de Melun-Sénart
Melun, France
Start Date
November 9, 2021
Primary Completion Date
December 31, 2021
Completion Date
March 1, 2022
Last Updated
April 3, 2023
122
ACTUAL participants
plasmatic SARS-CoV-2 RNA quantification
DIAGNOSTIC_TEST
Lead Sponsor
Hopital of Melun
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04466098